1. Home
  2. TMDX vs LGN Comparison

TMDX vs LGN Comparison

Compare TMDX & LGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TransMedics Group Inc.

TMDX

TransMedics Group Inc.

HOLD

Current Price

$67.93

Market Cap

3.8B

Sector

Health Care

ML Signal

HOLD

LGN

Legence Corp.

HOLD

Current Price

$98.83

Market Cap

3.6B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
TMDX
LGN
Founded
1998
1963
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.8B
3.6B
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
TMDX
LGN
Price
$67.93
$98.83
Analyst Decision
Buy
Strong Buy
Analyst Count
9
17
Target Price
$148.22
$59.50
AVG Volume (30 Days)
1.2M
1.7M
Earning Date
05-05-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
382.18
N/A
EPS
0.20
N/A
Revenue
$605,494,000.00
N/A
Revenue This Year
$24.25
$53.66
Revenue Next Year
$18.75
$11.99
P/E Ratio
$362.75
N/A
Revenue Growth
37.13
N/A
52 Week Low
$70.00
$28.31
52 Week High
$156.00
$102.64

Technical Indicators

Market Signals
Indicator
TMDX
LGN
Relative Strength Index (RSI) 19.80 78.37
Support Level N/A $42.97
Resistance Level $131.86 N/A
Average True Range (ATR) 5.31 4.38
MACD -3.88 1.42
Stochastic Oscillator 0.17 87.67

Price Performance

Historical Comparison
TMDX
LGN

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

About LGN Legence Corp.

Legence Corp is a provider of engineering, installation and maintenance services for mission-critical systems in buildings. It focuses on high-growth sectors that have technically demanding buildings, including technology, life sciences, healthcare and education. The company specializes in designing, fabricating and installing complex HVAC, process piping and other mechanical, electrical and plumbing (MEP) systems for new facilities and upgrading HVAC, lighting and building controls in existing facilities to make them more energy efficient and sustainable.

Share on Social Networks: